XML Persian Abstract Print


1- PhD student of the department of biophysics, faculty of biological sciences, Tarbiat Modares University, Tehran, Iran
2- Department of Biophysics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran , parviz@modares.ac.ir
3- Department of Brain and Cognitive Sciences, Royan institute for stem cell biology and technology, Tehran, Iran
4- Department of Medical Physics and Engineering, School of Medicine, Shiraz University of Medical Sciences
Abstract:   (233 Views)
Aims
Alzheimer's disease (AD) is a neurodegenerative disease characterized by the progressive loss of neurons leading to cognitive and memory decay. Accumulation of phosphorylated cis-tau inside neurons is considered a factor in AD's pathological features. This study investigated the effects of extremely low-frequency (EMF) and radiofrequency (RF) electromagnetic fields on the proliferation and expression of phosphorylated tau in SH-SY5Y neuroblastoma cells.
Materials and Methods
SH-SY5Y cells treated were exposed to 50 Hz, 20 mT EMF,  and 900 MHz for 24, 48, 72, and 96 hours, and the number of the viable cell were determined by MTT assay. Tau protein phosphorylation level was examined after exposure to EMF and RF at different time intervals.
Results
Exposure to the EMF and RF alone had no significant effect on the viability of SH-SY5Y cells compared to sham-exposed cells. However, the expression of phosphorylated cis-tau was significantly increased after exposure.
Conclusion
This study suggests that exposure of human neuroblastoma cells to a 50 Hz electromagnetic field and 900 MHz radiofrequency might induce phosphorylated cis-tau and thus enhance the potency of AD.
     
Article Type: Original Research | Subject: Molecular biotechnology
Received: 2023/01/19 | Accepted: 2023/07/12

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.